Clinical benefit of direct oral anticoagulants vs. vitamin-K antagonist in octogenarians with atrial fibrillation

MLA

Bonanad C, et al. “Clinical Benefit of Direct Oral Anticoagulants vs. Vitamin-K Antagonist in Octogenarians with Atrial Fibrillation.” European Heart Journal, vol. 42, Oct. 2021. EBSCOhost, https://doi.org/10.1093/eurheartj/ehab724.2827.

APA

Bonanad C, Garcia-Blas S, Villanueva P, Ariza A, Tarazona F, Bertomeu-Gonzalez V, Facila L, Torres J, Nunez J, & Cordero A. (2021). Clinical benefit of direct oral anticoagulants vs. vitamin-K antagonist in octogenarians with atrial fibrillation. European Heart Journal, 42. https://doi.org/10.1093/eurheartj/ehab724.2827

Chicago

Bonanad C, Garcia-Blas S, Villanueva P, Ariza A, Tarazona F, Bertomeu-Gonzalez V, Facila L, Torres J, Nunez J, and Cordero A. 2021. “Clinical Benefit of Direct Oral Anticoagulants vs. Vitamin-K Antagonist in Octogenarians with Atrial Fibrillation.” European Heart Journal 42 (October). doi:10.1093/eurheartj/ehab724.2827.